Ongoing research and development efforts within the domain of Kidney Replacement Therapies are expected to significantly transform the landscape of renal care, aiming to improve patient outcomes and quality of life, and offering new and enhanced treatment options for patients facing end-stage renal disease.
In this session, some of the recent advances in the field will be presented, ranging from improved dialyzer membranes to fully implantable filters. These developments will be placed in its clinical context by medical experts Stephen Ash and Karin Gerritsen. Their expertise will help attendees understand the broader impact of these innovations and the trajectory of future developments in kidney health.
STEVE ASH
HemoCleanse Technologies
KARIN GERRITSEN
UMC Utrecht
HANNAH BAUER
Xeltis B.V.
DIMITRIOS STAMATIALIS
University of Twente, The Netherlands